Exabis Library
Welcome to the e-CCO Library!
P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT Study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P699: Radiologic response reduces the risk of small-bowel surgery in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P699: Ustekinumab therapy after biologic failure in patients with Crohn's Disease – A real-world single centre experience
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P700 Effect of vitamin D in disease activity score and clinical relapse in patients with inflammatory bowel disease: A systematic review and meta-analysis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P700: A high CRP before surgery and early medical prophylaxis predict postoperative endoscopic Crohn’s disease recurrence
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P700: Epidemiology of genital lymphoedema as the initial presentation of paediatric Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P700: Perceptions towards established and emerging dietary therapies for Crohn's disease management among the adult patients: results from a questionnaire survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P700: The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relatives
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P701 New onset spondyloarthropathy in vedolizumab treated IBD patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P701: A time-to-event model relating infliximab trough concentrations to the risk of relapse after extending the infusion interval
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P701: Compositional and functional alterations of the gut microbiome are associated with impaired intestinal permeability in healthy relatives of patients with Crohn's disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P701: Late-onset Crohn's disease is associated with high risk of intestinal perforation and low risk of perianal fistula as compared with early-onset Crohn's disease: the CONNECT cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P701: Quality of life of patients with inflammatory bowel diseases who live with an ostomy: Results of a French national survey
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P701: The comparative safety of different intravenous iron preparations in inflammatory bowel disease: a systematic review and network meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P702 Treatment decisions in older inflammatory bowel disease patients: Applying gut feeling in an evidence-based era? A qualitative study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P702: Clinical and biomarker remission is maintained after switch from monthly dosed intravenous to subcutaneous maintenance treatment with vedolizumab in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P702: F-calprotectin use in inflammatory bowel disease is characterized by improved diagnostic accuracy, less patient harm and decreased costs, compared with conventional serological markers and colonoscopy. A cost-effectiveness study in Italy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P702: Faecal Microbiota Transplantation Sculpts the faecal and mucosal microbial and metabolomic profiles in patients with Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P702: Head-to-head comparison of biological drugs in the treatment of ulcerative colitis: Suggestions from a real-life, inception cohort, single-centre study on consecutive post-marketing treatments
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM